Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

Summary by Enid News & Eagle
Interim results from Phase 2b clinical trial of RAD 101 showed 92% of evaluable participants met the primary endpoint of MRI concordance in imaging study of patients with brain metastases

1 Articles

Enid News & EagleEnid News & Eagle
Lean Left

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

Interim results from Phase 2b clinical trial of RAD 101 showed 92% of evaluable participants met the primary endpoint of MRI concordance in imaging study of patients with brain metastases

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news in on Wednesday, January 28, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Enid icon

Enid

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal